This month marks the one-year anniversary of the Food and Drug Administration approving hydroxychloroquine to treat COVID-19. Needless to say, the agency will not be commemorating its endorsement of an ineffective drug.
The FDA needs a public health visionary
The FDA needs a public health visionary
The FDA needs a public health visionary
This month marks the one-year anniversary of the Food and Drug Administration approving hydroxychloroquine to treat COVID-19. Needless to say, the agency will not be commemorating its endorsement of an ineffective drug.